Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
J Natl Cancer Inst. 2010 Aug 4;102(15):1131-47. doi: 10.1093/jnci/djq218. Epub 2010 Jul 21.
A putative tumor suppressor gene at chromosome 10p15, which contains KLF6 and other genes, is predicted to be lost during melanoma development, and its identity is unknown. In this study, we investigated the biological roles and identity of this tumor suppressor gene.
The human UACC 903 melanoma cell line containing introduced DNA fragments from the 10p15 region with (10E6/3, 10E6/11, and 10E6/18) and without (10ER4S.2/1) the tumor suppressor gene was used. Xenograft tumors were generated in a total of 40 mice with melanoma cell lines, and tumor size was measured. Cells were cultured on plastic or a gel of type I collagen. Viability, proliferation, and apoptosis were assessed. Expression of KLF6 protein was assessed by immunohistochemistry and immunoblot analysis. Expression of phosphorylated Erk1/2 and cyclin D1 was assessed by immunoblot analysis. Protein expression of KLF6 was inhibited with small interfering RNA (siRNA). KLF6 protein expression was assessed in 17 human nevi and human melanoma specimens from 29 patients. Statistical analyses were adjusted for multiple comparisons by use of Dunnett method. All statistical tests were two-sided.
Melanoma cells containing KLF6 generated smaller subcutaneous xenograft tumors with fewer proliferating cells than control cells. When grown on collagen 1, viability of cells with ectopic KLF6 expression (72%) was lower than that of control cells (100%) (group difference = -28%, 95% confidence interval = -31.3% to -25.2%, P < .001). Viability of melanoma cells with or without the KLF6 tumor suppressor gene on plastic dishes was similar. When KLF6 expression was inhibited with KLF6 siRNA, viability of cells with the tumor suppressor gene on collagen I gel increased compared with that of control cells carrying scrambled siRNA. KLF6 protein was detected in all nevi examined but not in human metastatic melanoma tissue examined. Ectopic expression of KLF6 protein in melanoma cells grown on collagen I decreased levels of phosphorylated Erk1/2 and cyclin D1 in the mitogen-activated protein kinase signaling pathway.
In melanoma cells, the tumor suppressor gene at 10p15 appears to be KLF6. Signaling from the collagen I-rich extracellular matrix appears to be involved in the tumor suppressive activity of KLF6 protein.
在黑色素瘤发展过程中,预测染色体 10p15 上的一个假定的肿瘤抑制基因(包含 KLF6 和其他基因)会丢失,但其身份未知。在这项研究中,我们调查了这个肿瘤抑制基因的生物学作用和身份。
使用含有来自 10p15 区域的 DNA 片段的人 UACC 903 黑素瘤细胞系(10E6/3、10E6/11 和 10E6/18 有肿瘤抑制基因,10ER4S.2/1 无肿瘤抑制基因)。用黑素瘤细胞系在总共 40 只小鼠中生成异种移植肿瘤,并测量肿瘤大小。细胞在塑料或 I 型胶原凝胶上培养。评估细胞活力、增殖和凋亡。通过免疫组化和免疫印迹分析评估 KLF6 蛋白的表达。通过免疫印迹分析评估磷酸化 Erk1/2 和细胞周期蛋白 D1 的表达。用小干扰 RNA(siRNA)抑制 KLF6 蛋白表达。评估 17 个人痣和 29 名患者的人黑色素瘤标本中 KLF6 蛋白的表达。通过 Dunnett 法对多组比较进行了统计分析的调整。所有统计检验均为双侧检验。
含有 KLF6 的黑素瘤细胞生成的皮下异种移植肿瘤体积较小,增殖细胞较少。当在胶原 I 上生长时,异位表达 KLF6 的细胞的活力(72%)低于对照细胞(100%)(组间差异=-28%,95%置信区间=-31.3%至-25.2%,P<0.001)。在塑料培养皿上,有或没有 KLF6 肿瘤抑制基因的黑素瘤细胞的活力相似。用 KLF6 siRNA 抑制 KLF6 表达后,与携带对照 siRNA 的细胞相比,在胶原 I 凝胶上生长的携带肿瘤抑制基因的细胞的活力增加。在所有检查的痣中均检测到 KLF6 蛋白,但在检查的人转移性黑色素瘤组织中未检测到。在胶原 I 上生长的黑素瘤细胞中异位表达 KLF6 蛋白可降低丝裂原激活蛋白激酶信号通路中磷酸化 Erk1/2 和细胞周期蛋白 D1 的水平。
在黑素瘤细胞中,10p15 上的肿瘤抑制基因似乎是 KLF6。富含 I 型胶原的细胞外基质的信号似乎参与了 KLF6 蛋白的肿瘤抑制活性。